Cite

HARVARD Citation

    Sakai, Y. et al. (2020). Hemophagocytic syndrome associated with pembrolizumab therapy successfully controlled by cyclosporin. Journal of dermatology. 47 (12), pp. e422-e423. [Online]. 
  
Back to record